Terumo Medical Corporation
Clinical trials sponsored by Terumo Medical Corporation, explained in plain language.
A medical device company, subsidiary of Terumo Corporation.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New stent aims to open blocked leg arteries
Disease control CompletedThis study tests a self-expanding stent designed to open narrowed or blocked iliac arteries in the pelvis. About 75 people with moderate to severe leg pain or ulcers will receive the stent. Researchers will check for complications like death, amputation, or need for repeat treatm…
Phase: NA • Sponsor: Terumo Medical Corporation • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New device aims to seal artery punctures faster and safer
Disease control CompletedThis study tested a device called Cross-Seal that helps close large holes in the main leg artery after heart procedures. It involved 147 adults who needed artery access with large sheaths. The goal was to see if the device could stop bleeding quickly and safely without major comp…
Phase: NA • Sponsor: Terumo Medical Corporation • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC
-
New Plaque-Shaving device shows promise in tiny Leg-Artery study
Disease control CompletedThis completed study tested a handheld device called the Kaitoh Atherectomy System in 9 people with peripheral artery disease (PAD). The device uses a rotating blade to shave away plaque buildup in leg arteries, aiming to restore blood flow. Researchers checked for safety and how…
Phase: NA • Sponsor: Terumo Medical Corporation • Aim: Disease control
Last updated Jun 26, 2026 16:14 UTC
-
Real-World data on HydroPearl embolization through the wrist
Knowledge-focused CompletedThis completed registry study collected real-world data on 99 patients receiving HydroPearl microspheres to block blood flow to conditions like uterine fibroids, arteriovenous malformations, hypervascular tumors, and benign prostatic hyperplasia. The procedure was done through th…
Sponsor: Terumo Medical Corporation • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:23 UTC